CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike shares rose 5.6% to $483.88 Wednesday, leading gains in cybersecurity stocks after ADP data showed weaker-than-expected U.S. private payroll growth. Cantor Fitzgerald reiterated an Overweight rating and $590 target, citing strong subscription momentum. CrowdStrike, Amazon Web Services, and Nvidia launched a cybersecurity startup accelerator focused on AI. Investors await Friday’s U.S. jobs report and CrowdStrike’s fiscal year-end.
Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

Ambarella shares fell 12.5% to $70.54 Wednesday afternoon after reversing sharply from a session high of $82.10, despite unveiling its new CV7 edge AI chip and a developer platform at CES. The drop outpaced the broader semiconductor index, which slipped 1.27%. Investors are weighing the impact of new products against uncertain near-term demand and the upcoming earnings report.
Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

Varonis shares rose 8.3% to $36.06 by midday Wednesday, outpacing the Nasdaq’s 0.7% gain. Cantor Fitzgerald cut its price target to $50 from $60 but maintained an Overweight rating, citing SaaS growth and strong net revenue retention. Investors are watching early February results for signs of recurring revenue and churn. The stock remains down nearly 35% over six months.
TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

TORM shares rose 6.7% to $21.85 after Oaktree Capital’s stake dropped below one-third, triggering a governance overhaul and ending special voting rights. Deputy Chairman David Weinstein exited the board immediately. Hafnia recently acquired 13.97% of TORM and may explore a business combination. Investors await the Feb. 26 annual report and the cancellation of B and C shares.
7 January 2026
Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase shares fell 1.6% to $246.50 by midday Wednesday as bitcoin and ether prices declined. Director Fred Wilson sold 10,000 shares for about $2.34 million under a pre-set plan, a filing showed. Analyst opinions split on whether Coinbase’s trading volumes are dropping too quickly. Morgan Stanley filed to launch bitcoin and solana ETFs, while Barclays invested in stablecoin startup Ubyx.
Trump’s Venezuela oil plan starts now: 30–50 million barrels headed for U.S.

Trump’s Venezuela oil plan starts now: 30–50 million barrels headed for U.S.

The U.S. will begin shipping 30–50 million barrels of seized Venezuelan crude to the United States, with sales to continue indefinitely, a senior Trump administration official said Wednesday. Washington will ease some sanctions to keep oil flowing after U.S. forces captured President Maduro. Chevron remains the only U.S. firm authorized to export Venezuelan crude. Brent crude fell to $60.70 as traders weighed increased supply.
7 January 2026
China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips

China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips

Chinese authorities have told some tech firms to stop placing new orders for Nvidia’s H200 AI chips, the Information reported, as Beijing considers import rules. Nvidia executives say demand in China remains strong but export approvals are pending. The move comes as China pushes for domestic alternatives and tightens restrictions on foreign AI chips.
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies shares climbed 6.5% to $17.15 by midday Wednesday, outpacing broader market gains. Biotech ETFs rose about 2.5%. A Form 4 showed Chief People Officer Francis Lo sold 3,125 shares on Jan. 2 under a prearranged 10b5-1 plan, after exercising options. The company is set to present at the J.P. Morgan Healthcare Conference on Jan. 12.
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard shares rose 0.7% to $584.60 by midday Wednesday, outperforming Visa, which slipped 0.4%. Morgan Stanley maintained an “overweight” rating, citing growth in cross-border fees and security services. About 1.36 million Mastercard shares traded as investors watched for Friday’s U.S. jobs report and the Jan. 9 dividend record date. U.S. private payrolls rose less than expected in December, ADP reported.
7 January 2026

Stock Market Today

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

7 February 2026
The Philadelphia Semiconductor Index jumped 5.7% to 8,048.6 on Friday, with Nvidia up 7.87% and AMD rising 8.28%. The surge followed new forecasts showing global chip sales could hit $1 trillion in 2026. Amazon expects a 50% increase in capital spending this year, fueling demand for chips. The Dow Jones crossed 50,000, helped by gains in chipmakers.
Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Go toTop